Yuanyuan Qian and Emily Tharnish
"Structural Evolution from Crizotinib to Lorlatinib: A Case Study of Anaplastic Lymphoma Kinase (ALK) Inhibitors" Yuanyuan Qian
"Computer-Aided Synthesis Design" Emily Tharnish
"Structural Evolution from Crizotinib to Lorlatinib: A Case Study of Anaplastic Lymphoma Kinase (ALK) Inhibitors" Yuanyuan Qian
"Computer-Aided Synthesis Design" Emily Tharnish